Loading…

Complications of imaging-assisted port catheters and factors affecting complications/Goruntuleme esliginde takilan port kateterlerinin komplikasyonlari ve komplikasyonlara etki eden faktorler

Purpose: This research investigates complications associated with Imaging-Assisted Port Catheters (IAPCs) to provide insights for healthcare professionals involved in their usage. The study aims to optimize patient safety, implement preventive strategies, and guide evidence-based decision-making in...

Full description

Saved in:
Bibliographic Details
Published in:Pamukkale Medical Journal 2024-04, Vol.17 (2), p.303
Main Authors: Tekinhatun, Muhammed, Arslan, Muhammet, Aslan, Halil Serdar, Demirci, Huseyin Gokhan Yavas Mahmut, Koluman, Basak Unver, Alver, Kadirhan
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: This research investigates complications associated with Imaging-Assisted Port Catheters (IAPCs) to provide insights for healthcare professionals involved in their usage. The study aims to optimize patient safety, implement preventive strategies, and guide evidence-based decision-making in the clinical use of IAPCs. Materials and methods: A retrospective study comprising 1247 patients who underwent IAPC placement in the Interventional Radiology Unit between 01.09.2012-01.09.2020 was conducted. Data, including indications for port placement, complications, duration of port stay, and reasons for explantation, were extracted from electronic medical records. Comparative analysis with surgically implanted ports was performed, and the efficacy and safety of imaging-guided port implantation were assessed. Results: The study predominantly involved right internal jugular vein placement (93.8%). Major complications did not occur during the 7 to 1330 days of port usage. The average usage period was 243 days, totaling 310,503 catheter-days. Infectious complications were the most common (4.8%), significantly higher (13.9%) in hematological malignancies. Multivariate analysis revealed a significantly increased complication rate in hematological malignancy patients (p
ISSN:1309-9833
DOI:10.31362/patd.1368908